Bloomberg
Salix Blames Failed Merger on New Inversion Rules
Oct. 3 -- Bloomberg's Erik Schatzker reports on today's top headlines on Market Makers.
Bloomberg
Allergan Seeks to Fend Off Hostile Takover by Vleant
Nov. 6 -- Bloomberg's Mark Crumpton reports on today's top news stories on Bottom Line. (Source: Bloomberg)
Bloomberg
A-Rod Admits PED Use as a NY Yankee: Miami Herald
Nov. 6 -- Bloomberg's Betty Liu reports on today's top news stories on In The Loop.
Curated Video
The EPA was blasted during a Senate hearing Tuesday for allowing the public to learn that traces of pharmaceuticals are in much of the nation's drinking water from an AP investigative series, not the federal government.
HEADLINE: EPA blasted over drugs in drinking water
CAPTION: The EPA was blasted during a Senate hearing Tuesday for allowing the public to learn that traces of pharmaceuticals are in much of the nation's drinking water from an AP...
Bloomberg
Is an M&A Frenzy Coming to the Drug Industry?
May 31 -- Bloomberg Intelligence's Asthika Goonewardene discusses the outlook for pharmaceutical stocks with Bloomberg's Shery Ahn on "Bloomberg Markets."
Bloomberg
The Top Three Stocks to Watch in Asia Today
April 12 -- In today's "Stock Exchange," Bloomberg's Shery Ahn, David Ingles and Haidi Lun discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
The Top Three Stocks to Watch in Asia Today
Feb. 24 -- In today's "Stock Exchange," Bloomberg's Yvonne Man, Juliette Saly and Shery Ahn discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
Tainted Meds Versus No Meds at All: The FDA's Compromise
July 22 -- Bloomberg's Anna Edney discusses the amount of supplies U.S. pharmaceutical companies get from foreign drugmakers. She speaks with Bloomberg's Matt Miller and David Gura on "Bloomberg Markets."
Bloomberg
Novo Nordisk Slashes Long-Term Profit Growth on Pricing
Oct. 28 -- Novo Nordisk shares fell by the most in more than 14 years as the company slashed its long-term profit growth target in half on U.S. pricing pressure. Bloomberg Intelligence's Sam Fazeli reports on "Bloomberg Surveillance."
Bloomberg
J&J Said to Make Takeover Approach for Actelion
Nov.25 -- Johnson & Johnson has approached Actelion about a potential takeover of the $17 billion Swiss drugmaker as the U.S. health-care giant works to expand its pharmaceutical lineup, people familiar with the matter said. Bloomberg...
Bloomberg
Trump Calls Drug Pricing ‘Astronomical’
Jan.31 -- President Donald Trump told drugmakers at a White House meeting on Tuesday that they were charging too much and promised to get better bargains for government health programs. Bloomberg’s Drew Armstrong reports on...
Bloomberg
Cigna Sues Anthem After Ending Merger Agreement
Feb.14 -- Cigna sued its merger partner Anthem after ending their $48 billion agreement, a deal that had been blocked by a U.S. judge. Anthem, minutes later, said Cigna had no right to terminate the deal. Bloomberg's Drew Armstrong has...
Bloomberg
Gabelli's Jonas Doesn't Expect Much Change at Valeant
Jun.19 -- Jeff Jonas, a portfolio manager at Gabelli & Co., discusses billionaire hedge-fund manager John Paulson joining the board of Valeant Pharmaceuticals International Inc. He speaks with Bloomberg's Scarlet Fu and Julia Chatterley...
Bloomberg
Sanpower's SVP Says Dendreon Deal Is a Milestone
Jun.29 -- Xu Fang, senior vice president and Dendreon Chairman at Sanpower group, discusses completing the Dendreon purchase from Valeant. She speaks on "Bloomberg Markets: Asia."
Bloomberg
'Pharma Bro' Martin Shkreli Reacts to Fraud Conviction
Aug.04 -- Martin Shkreli, notorious for raising the price of a potentially life-saving drug by 5,000 percent, reacts to being found guilty of defrauding investors in two hedge funds and in Retrophin Inc., a pharmaceutical company he...
Bloomberg
Bain, Cinven Clinch Stada Purchase in $6.3 Billion Deal
Aug.18 -- Bain Capital and Cinven have succeeded in their pursuit of Stada Arzneimittel AG with an offer of $6.3 billion. Bloomberg's Sarah Syed reports on "Bloomberg Markets: European Close."
Bloomberg
Outlook for Pharma in 2018
Jan.02 -- 2017 was another active year in the pharmaceutical space highlighted by cancer drugs developments and diverging performance amongst the biggest drug makers. So what does 2018 bring? Bloomberg Intelligence's Sam Fazeli discusses...
Bloomberg
China Looks to Build Pharma Giants
Jun.19 -- In laboratories across China, scientists are racing to catch up with and then overtake their Western counterparts. Bloomberg's Drew Armstrong has more on "What'd You Miss?"
Bloomberg
Why Blackstone Is Betting on Costly Drug Trials
Apr.26 -- Blackstone Group LP is betting that it can use its considerable financial muscle to succeed where even the biggest drugmakers need help: getting promising medications over the finish line. Bloomberg's Rebecca Spalding reports...
Bloomberg
JPMorgan Sees Pharma M&A ‘Very Active,’ But ‘Different’ in 2020
Jan.14 -- Christopher Schott, senior pharmaceuticals analyst at JPMorgan, discusses the outlook for M&A deals in the pharmaceutical and biotech industries. He speaks on the sidelines of the JPMorgan Healthcare Conference on "Bloomberg...
Bloomberg
Drug Makers Snap Up Reservation Deals Over Virus Vaccines
Aug.05 -- While pharmaceutical firms are racing to develop a coronavirus vaccine, several of them have been snapping up deals with governments to be the first in line to get the drug once it comes out. Bloomberg’s Michelle Cortez reports...
Bloomberg
Biden Doubles Order of J&J One-Shot Covid Vaccine
Mar.10 -- President Joe Biden said doubling the U.S. order of Johnson & Johnson’s one-shot Covid-19 vaccine will help build a stockpile larger than the country’s population, providing backup doses to meet unexpected needs as new variants...
Bloomberg
Hong Kong Says Experts to Discuss Sinovac Vaccine
Feb.10 -- Hong Kong Food and Health Secretary Sophia Chan discusses the government's Covid-19 vaccination rollout plan and the efforts to fight the pandemic. She speaks with Rishaad Salamat and Haslinda Amin on "Bloomberg Markets: Asia."